Pictet Asset Management Holding SA Buys 4,871 Shares of Sotera Health (NASDAQ:SHC)

Pictet Asset Management Holding SA grew its position in Sotera Health (NASDAQ:SHC) by 29.1% in the fourth quarter, Holdings Channel reports. The fund owned 21,593 shares of the company’s stock after acquiring an additional 4,871 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Sotera Health were worth $295,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Blue Trust Inc. grew its holdings in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after purchasing an additional 1,121 shares during the period. PNC Financial Services Group Inc. grew its stake in shares of Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company’s stock worth $127,000 after purchasing an additional 2,627 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its holdings in Sotera Health by 17.3% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock valued at $217,000 after purchasing an additional 2,340 shares during the period. Finally, Oak Thistle LLC bought a new position in Sotera Health during the 4th quarter worth $222,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Barclays reduced their price target on Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $15.20.

Sotera Health Trading Down 6.4 %

NASDAQ:SHC opened at $10.60 on Friday. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm’s fifty day moving average is $12.21 and its 200-day moving average is $13.57. The firm has a market cap of $3.00 billion, a P/E ratio of 42.40 and a beta of 1.88.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.